Martin Sjöström

University of California, San Francisco — United States

Medicine · Health Sciences

29h-index3.2kcitations478works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(218), Cancer Immunotherapy and Biomarkers(94), Cancer, Lipids, and Metabolism(78), Immunotherapy and Immune Responses(77), Cancer Genomics and Diagnostics(64)

Publications478 total

Supplementary Tables S5-S11 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
2025Open Access
Supplementary Figure S1 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
2025Open Access
Supplementary Figure S1 from Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer
2025Open Access
Supplementary Figure S5 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
2025Open Access
Supplementary Figure S4 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
2025Open Access
Supplementary Figure S3 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
2025Open Access
Supplementary Tables S1-S4 from Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer
2025Open Access
Supplementary Tables S1-S4 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
2025Open Access
Study protocol S1 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
2025Open Access
Supplementary Figure S2 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
2025Open Access
Supplementary Table 3. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Supplementary Data 1. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Supplementary Figure 3. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Supplementary Figure 8. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Supplementary Figure 7. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Supplementary Data 2. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Supplementary Figure 6. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Supplementary Figure 4. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Supplementary Table 1. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
Supplementary Figure 2. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
2025Open Access
page 1 of 24Next →

Frequent Co-authors

Felix Y. Feng(30), David A. Quigley(15), Shuang G. Zhao(12), Rahul Aggarwal(11), Eric J. Small(11), Emma Niméus(11), Mårten Fernö(11), Adam Foye(10), Per Malmström(10), Meng Zhang(9), Joshi J. Alumkal(9), Jonathan Chou(9), Raunak Shrestha(9), Joshua M. Lang(8), Erik Holmberg(8), Per Karlsson(8), Linda Hartman(7), Arian Lundberg(7), William S. Chen(6), Lisa N. Chesner(6)